Which Serum Cortisol after High Dose Short Synacthen Test, 30 or 60 Minutes?

Research Article

Austin J Endocrinol Diabetes. 2015;2(1): 1030.

Which Serum Cortisol after High Dose Short Synacthen Test, 30 or 60 Minutes?

Abbas Ali Mansour*, Ali Hussein Ali Alhamza,Ammar Mohammed Saeed Abdullah Almomin

Endocrine and Metabolism Division, Al-Faiha Diabetes Endocrine and Metabolism Center (FDEMC), Basrah College of Medicine, Iraq

*Corresponding author: Abbas Ali Mansour, Director of Al-Faiha Diabetes Endocrine and Metabolism Center (FDEMC), Endocrine and Metabolism Division, Basrah College of Medicine, Iraq,

Received: December 13, 2014; Accepted: January 02, 2015; Published: January 06, 2015

Abstract

Background: Short synacthen (cosyntropin) test, has replaced the insulin stress test as the first-line test to assess adrenal insufficiency. The aim of this study was to determine the utility of the 30 and 60 minute cortisol measurement in the high dose (250 μg) short synacthen test.

Methods: Cross sectional study was conducted by reviewing the database of patients underwent short synacthen test in Al-Faiha Diabetes Endocrine and Metabolism Center (FDEMC) for the peroid from November 2009 to May 2013.

Results: Study participants includes 435 patients. The cortisol response in short synacthen test was sufficient in198 (45.5%) patients and abnormal in 237(54.4%) patients. It was insufficient at 30 minute only in 56 (12.9%) patients, insufficient at 60 minute only in 5 (1.1%) patients and insufficient at both 30 minute and 60 minute in 176 (40.5 %) patients. Insufficient at 30 minute and sufficient at 60 minute was seen in 120(27.6 %) patients. This means that the false negative test if the 60 minute sample was not taken was 27.6 %.Only 5 (1.1%) patients with normal response at 30 minutes will regress to response at 60 minutes.

Conclusion: measuring both 30 minute and 60 minute cortisol level are necessary and at 60 minute is fundamental in interpretation of short synacthen test.

Keywords: Adrenal insufficiency; Cortisol; Short synacthen test

Introduction

Adrenal insufficiency is caused by either primary adrenal failure (mostly due to autoimmune adrenalitis) or by hypothalamic-pituitary impairment of the corticotropic axis (predominantly due to pituitary disease). It is a rare disease, but is life threatening when overlooked [1].

Symptoms commonly associated with adrenal insufficiency are “fatigue” (lack of energy or stamina), abdominal pain, nausea and dizziness (hypotension symptoms) and all are nonspecific [2].

Although different tests for adrenal insufficiency have been developed, few have been adequately studied and many are inconvenient for use in outpatient clinical settings [3]. Short synacthen (cosyntropin) test (SST) has replaced the insulin stress test as the first-line test to assess adrenal insufficiency and has received considerable attention regarding its sensitivity and specificity [4, 5].

The synthetic polypeptide Synacthen (Tetracosactrin BP) has a structure identical to the N-terminal 24 amino acids of Adrenocorticotrophic Hormone (ACTH). It has a short duration of action and permits a rapid and convenient screening test for the assessment of adrenocortical function by measuring cortisol response. Routinely taking a 60 minute sample would improve the specificity of SST and avoid misdiagnosis of adrenal insufficiency [6]. In view of biological and analytical variation, it is recommended that each laboratory should use their own results validated at the three time points [6]. Half-life for synacthen (cosyntropin) is only 15 minutes. Administration is by intravenous or intramuscular injection and a rise in cortisol should generally be seen around 30 minutes after administration. Plasma cortisol levels usually peak about 45 to 60 minutes after injection [7]. Comparison of the plasma cortisol response at 30 minutes with both short ACTH tests and the peak in the insulin tolerance test did not reveal differences [8].

The cosyntropin test works well in patients with primary adrenal insufficiency, but the lower sensitivity in patients with secondary adrenal insufficiency [7].

All laboratories in UK stated that a dosage of 250μg synacthen administered during the Synacthen test and most generally agreed that a basal and 30 minute blood sample should be taken, while a significant number analyzed a 60 minute sample [4]. Two UK surveys conducted show an increasing trend in clinicians discarding the 60 minute sampling time and relying more heavily on the 30 minute sample [4-9]. The only time point that has been validated against the insulin tolerance test. Two studies stated that the 60 minute sample has no benefit over the 30 minute sample [10, 11].

The definition of the ‘normal’ response to synacthen should be both gender and method related at all time points [12].

The aim of this study was to determine the utility of the 30 and 60 minute cortisol measurement in the high dose (250 μg) short synacthen test.

Material and Methods

Cross sectional study was conducted by reviewing the database of patients underwent short synacthen test in Al-Faiha Diabetes Endocrine and Metabolism Center (FDEMC) for the period from November 2009 to May 2013 in Basrah (Southern Iraq).

Inclusion criteria

Patients referred to Al-Faiha Diabetes Endocrine and Metabolism Center (FDEMC) to assess adrenal function for following reasons.

Exclusion criteria

Pregnant women, those on oral contraceptive pills or corticosteroid use in the preceding one week and those with repeated short synacthen test.

Preparation

Short, or rapid, ACTH test, measurement of cortisol in blood is repeated 30 to 60 minutes after an intravenous 250μg ACTH injection (Tetracosactrin 0.25μg, Synacthen®; Ciba-Geigy, France). The patient does not need to be fasted. It was done at 8-10 AM. Blood samples were taken immediately before the test for the determination of basal serum cortisol concentration and at 30 minute and 60 minute thereafter [1].

Serum cortisol was measured with use of electro chemiluminescent (ECL) automated immunoassays applied on cobas e 411 analyzer (Roche) using 2nd generation platform of ECL technology at 0, 30 and 60 minute after intravenous or intramuscular synacthen (250 μg).

Interpretation of results

Normal response: Post-stimulation serum cortisol should be greater than 20 ug/dL (555 nmol/L) [4].

Statistical analysis

Statistical analysis was performed using a computer program package (SPSS 15 for Windows, Standard version, ©SPSS. Inc, USA) and a P value of <0.05 was considered significant.

Results

Study participants (Table 1) include 435 patients with mean age of 34.78 ± 11.85 year and age range 12-78 year. Of them women constitutes 64.6% with mean BMI of 25.36 ± 6.18 kg/m2. The mean basal cortisol in ug/dL was 9.68 ± 8.14, 30 minute cortisol 18.17 ± 11.03 and 60 minute cortisol was 21.41 ± 12.61.